[Use of tumor markers in patients on chronic hemodialysis].
Kuno
Tsutomu
T
Second Department of Internal Medicine, Nihon University School of Medicine.
Kaizu
Kazo
K
D000951:Antigens, Neoplasm / Q000097:blood; D015295:Antigens, Tumor-Associated, Carbohydrate / Q000097:blood; D015415:Biomarkers / Q000097:blood; D014408:Biomarkers, Tumor / Q000097:blood*; D002272:Carcinoembryonic Antigen / Q000097:blood; D005260:Female; D006801:Humans; D053539:Keratin-19; D007633:Keratins; D007676:Kidney Failure, Chronic / Q000150:complications; D008297:Male; D009369:Neoplasms / Q000175:diagnosis* / Q000209:etiology*; D010446:Peptide Fragments / Q000097:blood; D010455:Peptides / Q000097:blood; D010530:Peritoneal Dialysis / Q000009:adverse effects*; D010751:Phosphopyruvate Hydratase / Q000097:blood; D017430:Prostate-Specific Antigen / Q000097:blood; D011498:Protein Precursors / Q000097:blood; D011516:Prothrombin; D011994:Recombinant Proteins / Q000097:blood; D006435:Renal Dialysis / Q000009:adverse effects*; D015843:Serpins / Q000097:blood; D019396:Tissue Polypeptide Antigen / Q000097:blood; D000509:alpha-Fetoproteins / Q000032:analysis
D000951:Antigens, Neoplasm; D015295:Antigens, Tumor-Associated, Carbohydrate; D015415:Biomarkers; D014408:Biomarkers, Tumor; D002272:Carcinoembryonic Antigen; D053539:Keratin-19; D010446:Peptide Fragments; D010455:Peptides; D011498:Protein Precursors; D011994:Recombinant Proteins; D015843:Serpins; D019396:Tissue Polypeptide Antigen; D000509:alpha-Fetoproteins; C102012:antigen CYFRA21.1; C087079:pro-gastrin-releasing peptide (31-98); C051072:squamous cell carcinoma-related antigen; C008208:acarboxyprothrombin; D007633:Keratins; D011516:Prothrombin; D017430:Prostate-Specific Antigen; D010751:Phosphopyruvate Hydratase